In Silico Analysis of Acinetobacter baumannii Phospholipase D as a Subunit Vaccine Candidate

Acta Biotheoretica

Volumn 62, Issue 4, 2014, Pages 455-478

  Zadeh Hosseingholi, Elaheh ^a   Rasooli, Iraj ^a   Mousavi Gargari, Seyed Latif ^a  

^a SHAHED UNIVERSITY   (Iran)

Author keywords

Acinetobacter baumannii; In silico; Phospholipase D; Vaccine

Indexed keywords

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); MURINAE;

BACTERIAL VACCINE; EPITOPE; PHOSPHOLIPASE D; SUBUNIT VACCINE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINO ACID SEQUENCE; BIOLOGICAL MODEL; CHEMICAL STRUCTURE; COMPUTER SIMULATION; ENZYMOLOGY; GENETICS; IMMUNOLOGY; PROTEIN TERTIARY STRUCTURE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINO ACID SEQUENCE; BACTERIAL VACCINES; COMPUTER SIMULATION; EPITOPES; MODELS, IMMUNOLOGICAL; MODELS, MOLECULAR; PHOSPHOLIPASE D; PROTEIN STRUCTURE, TERTIARY; VACCINES, SUBUNIT;

EID: 84930085226     PISSN: 00015342     EISSN: 15728358     Source Type: Journal    
DOI: 10.1007/s10441-014-9226-8     Document Type: Article

References (90)

1. Antunes LÕC, Imperi F, Carattoli A, Visca P (2011) Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS ONE 6:e22674. doi:10.1371/journal.pone.0022674
2. Apicella MA, Edwards JL, Gibson BW, Scheffler K (2007) Vaccine and compositions for the prevention and treatment of neisserial infections. Google Patents
3. Arias CA, Murray BE (2012) The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 10:266–278. doi:10.1038/nrmicro2761
4. Barh D, Misra AN, Kumar A (2010) In silico identification of dual ability of N. gonorrhoeae ddl for developing drug and vaccine against pathogenic Neisseria and other human pathogens. JPB 3(3):82–90. doi:10.4172/jpb.1000125
5. Benkert P, Tosatto SC, Schomburg D (2008) QMEAN: a comprehensive scoring function for model quality assessment. Proteins Struct Funct Bioinform 71:261–277. doi:10.1002/prot.21715
6. Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litran T (2012) Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections. Infect Immun 80:3381–3388. doi:10.1128/IAI.06096-11
7. Berjanskii M, Liang Y, Zhou J, Tang P, Stothard P, Zhou Y, Cruz J, MacDonell C, Lin G, Lu P (2010) PROSESS: a protein structure evaluation suite and server. Nucleic Acids Res 38:W633–W640. doi:10.1093/nar/gkq375
8. Bhasin M, Garg A, Raghava GPS (2005) PSLpred: prediction of subcellular localization of bacterial proteins. Bioinformatics 21:2522–2524. doi:10.1093/bioinformatics/bti309
9. Braun G (2008) Virulence mechanisms of Acinetobacter. In: Bergogne-Berezin E et al (eds) Acinetobacter biology and pathogenesis. Springer, Berlin, pp 145–154
10. Camp C, Tatum OL (2010) A review of Acinetobacter baumannii as a highly successful pathogen in times of war. Lab Med 41:649–657. doi:10.1309/LM90IJNDDDWRI3RE
11. Centers for Disease Control and Prevention (2013) Antibiotic resistance threats in the United States
12. Cerqueira GM, Peleg AY (2011) Insights into Acinetobacter baumannii pathogenicity. IUBMB Life 63:1055–1060. doi:10.1002/iub.533
13. Chandra S, Singh TR (2012) Linear B cell epitope prediction for epitope vaccine design against meningococcal disease and their computational validations through physicochemical properties. Netw Model Anal Health Inform Bioinform 1:153–159. doi:10.1007/s13721-012-0019-1
14. Chandra S, Singh D, Singh TR (2010) Prediction and characterization of T-cell epitopes for epitope vaccine design from outer membrane protein of Neisseria meningitidis serogroup B. Bioinformation 5:155. doi:10.6026/97320630005155
15. Chaplin PJ, De Rose R, Boyle JS, McWaters P, Kelly J, Tennent JM, Lew AM, Scheerlinck JP (1999) Targeting improves the efficacy of a DNA vaccine against Corynebacterium pseudotuberculosis in sheep. Infect Immun 67:6434–6438
16. Chen LY, Pan WW, Chen M, Li JD, Liu W, Chen G, Huang S, Papadimos TJ, Pan ZK (2009) Synergistic induction of inflammation by bacterial products lipopolysaccharide and fMLP: an important microbial pathogenic mechanism. J Immunol 182:2518–2524. doi:10.4049/jimmunol.0713933
17. Choo KH, Tan TW, Ranganathan S (2009) A comprehensive assessment of N-terminal signal peptides prediction methods. BMC Bioinform 10:S2. doi:10.1186/1471-2105-10-S15-S2
18. Davies MN, Flower DR (2007) Harnessing bioinformatics to discover new vaccines. Drug Discov Today 12:389–395. doi:10.1016/j.drudis.2007.03.010
19. de Leseleuc L, Chen W (2012) Recent advances in the immunopathogenesis of Acinetobacter Baumannii infection. In: Amal A (ed) Pulmonary infection. In Tech, Rijeka, pp 23–36
20. Dethlefsen L, Eckburg PB, Bik EM, Relman DA (2006) Assembly of the human intestinal microbiota. Trends Ecol Evol 21:517–523. doi:10.1016/j.tree.2006.06.013
21. Diaz AA, Tomba E, Lennarson R, Richard R, Bagajewicz MJ, Harrison RG (2010) Prediction of protein solubility in Escherichia coli using logistic regression. Biotechnol Bioeng 105:374–383. doi:10.1002/bit.22537
22. Dimitrov I, Flower DR, Doytchinova I (2013) AllerTOP—a server for in silico prediction of allergens. BMC Bioinform 14:1–9. doi:10.1186/1471-2105-14-S6-S4
23. Dobson CM (2004) Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol 15(1):3–16. doi:10.1016/j.semcdb.2003.12.008
24. Dorella FA, Pacheco LGC, Oliveira SC, Miyoshi A, Azevedo V (2006) Corynebacterium pseudotuberculosis: microbiology, biochemical properties, pathogenesis and molecular studies of virulence. Vet Res 37:201–218. doi:10.1051/vetres:2005056
25. Doytchinova IA, Flower DR (2007) VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform 8:4. doi:10.1186/1471-2105-8-4
26. Dyrlov Bendtsen J, Nielsen H, von Heijne G, Brunak S (2004) Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 340:783–795. doi:10.1016/j.jmb.2004.05.028
27. El-Manzalawy Y, Dobbs D, Honavar V (2008) Predicting linear B-cell epitopes using string kernels. J Mol Recognit 21:243–255. doi:10.1002/jmr.893
28. Emini EA, Hughes JV, Perlow D, Boger J (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55:836–839
29. Exton JH (1997) New developments in phospholipase D. J Biol Chem 272:15579–15582. doi:10.1074/jbc.272.25.15579
30. Fattahian Y, Rasooli I, Mousavi Gargari SL, Rahbar MR, Darvish Alipour Astaneh S, Amani J (2011) Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap). Microb Pathog 51:402–406. doi:10.1016/j.micpath.2011.09.004
31. Feasey NA, Dougan G, Kingsley RA, Heyderman RS, Gordon MA (2012) Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 379:2489–2499. doi:10.1016/S0140-6736(11)61752-2
32. Filloux A (2010) Secretion signal and protein targeting in bacteria: a biological puzzle. J Bacteriol 192:3847–3849. doi:10.1128/JB.00565-10
33. Fontaine MC, Baird G, Connor KM, Rudge K, Sales J, Donachie W (2006) Vaccination confers significant protection of sheep against infection with a virulent United Kingdom strain of Corynebacterium pseudotuberculosis. Vaccine 24:5986–5996. doi:10.1016/j.vaccine.2006.05.005
34. Geourjon C, Deleage G (1995) SOPMA: significant improvements in protein secondary structure prediction by consensus prediction from multiple alignments. Computer applications in the biosciences: CABIOS 11:681–684. doi:10.1093/bioinformatics/11.6.681
35. Ghannoum MA (2000) Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 13:122. doi:10.1128/CMR.13.1.122-143.2000
36. Guan P, Doytchinova IA, Zygouri C, Flower DR (2003) MHCPred: a server for quantitative prediction of peptide–MHC binding. Nucleic Acids Res 31:3621–3624. doi:10.1093/nar/gkg510
37. Hodgson AL, Krywult J, Corner LA, Rothel JS, Radford AJ (1992) Rational attenuation of Corynebacterium pseudotuberculosis: potential cheesy gland vaccine and live delivery vehicle. Infect Immun 60:2900–2905
38. Hodgson ALM, Carter K, Tachedjian M, Krywult J, Corner LA, McColl M, Cameron A (1999) Efficacy of an ovine caseous lymphadenitis vaccine formulated using a genetically inactive form of the Corynebacterium pseudotuberculosis phospholipase D. Vaccine 17:802–808. doi:10.1016/S0264-410X(98)00264-3
39. Ivanovska N (2003) Phospholipases as a factor of pathogenicity in microorganisms. J Mol Catal B Enzym 22:357–361. doi:10.1016/S1381-1177(03)00050-X
40. Jacobs AC, Hood I, Boyd KL, Olson PD, Morrison JM, Carson S, Sayood K, Iwen PC, Skaar EP, Dunman PM (2010) Inactivation of phospholipase D diminishes Acinetobacter baumannii pathogenesis. Infect Immun 78:1952. doi:10.1128/IAI.00889-09
41. Kolaskar AS, Tongaonkar PC (1990) A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 276:172–174. doi:10.1016/0014-5793(90)80535-Q
42. Kumar S, Srivastava G (2012) PRALINE, a protein multiple sequence alignment tool: user perspective analysis. GERF Bull Biosci 3(2):28–29
43. Lafuente EM, Reche PA (2009) Prediction of MHC-peptide binding: a systematic and comprehensive overview. Curr Pharm Des 15:3209–3220. doi:10.2174/138161209789105162
44. Liscovitch M, Czarny M, Fiucci G, Lavie Y, Tang X (1999) Localization and possible functions of phospholipase D isozymes. Biochim Biophys Acta (BBA) Mol Biol Lipids 1439:245–263. doi:10.1016/S1388-1981(99)00098-0
45. Mai V, Morris JG (2004) Colonic bacterial flora: changing understandings in the molecular age. J Nutr 134:459–464
46. Malkov S, Zivkovic MV, Beljanski MV, Zaric SD (2005) Correlations of amino acids with secondary structure types: connection with amino acid structure. arXiv preprint q-bio/0505046
47. McConnell MJ, Pachon J (2010) Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine. Vaccine 29:1–5. doi:10.1016/j.vaccine.2010.10.052
48. McConnell MJ, Dominguez-Herrera J, Smani Y, Lopez-Rojas R, Docobo-Perez F, Pachon J (2011) Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii. Infect Immun 79:518–526. doi:10.1128/IAI.00741-10
49. McGuffin LJ, Bryson K, Jones DT (2000) The PSIPRED protein structure prediction server. Bioinformatics 16:404–405. doi:10.1093/bioinformatics/16.4.404
50. McKean SC, Davies JK, Moore RJ (2007) Expression of phospholipase D, the major virulence factor of Corynebacterium pseudotuberculosis, is regulated by multiple environmental factors and plays a role in macrophage death. Microbiology 153:2203–2211. doi:10.1099/mic.0.2007/005926-0
51. McNamara PJ, Bradley GA, Songer JG (1994) Targeted mutagenesis of the phospholipase D gene results in decreased virulence of Corynebacterium pseudotuberculosis. Mol Microbiol 12:921–930. doi:10.1111/j.1365-2958.1994.tb01080.x
52. Moriel DG, Beatson SA, Wurpel DÓJ, Lipman J, Nimmo GR, Paterson DL, Schembri MA (2013) Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii. PLoS ONE 8:e77631. doi:10.1371/journal.pone.0077631
53. Nazarian S, Mousavi Gargari SL, Rasooli I, Amani J, Bagheri S, Alerasool M (2012) An in silico chimeric multi subunit vaccine targeting virulence factors of enterotoxigenic Escherichia coli (ETEC) with its bacterial inbuilt adjuvant. J Microbiol Methods 90:36–45. doi:10.1016/j.mimet.2012.04.001
54. Peleg AY, Seifert H, Paterson DL (2008) Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538. doi:10.1128/CMR.00058-07
55. Ponting CP, Kerr ID (1996) A novel family of phospholipase D homologues that includes phospholipid synthases and putative endonucleases: identification of duplicated repeats and potential active site residues. Protein Sci 5:914–922. doi:10.1002/pro.5560050513
56. Prabhavathy K, Perumal P, SundaraBaalaji N (2011) In silico identification of B- and T-cell epitopes on OMPLA and LsrC from Salmonella typhi for peptide-based subunit vaccine design. Indian J Biotechnol 10:440–451
57. Raman K, Yeturu K, Chandra N (2008) targetTB: a target identification pipeline for Mycobacterium tuberculosis through an interactome, reactome and genome-scale structural analysis. BMC Syst Biol 2:109. doi:10.1186/1752-0509-2-109
58. Roy A, Kucukural A, Zhang Y (2010) I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5:725–738. doi:10.1038/nprot.2010.5
59. Rubinstein ND, Mayrose I, Halperin D, Yekutieli D, Gershoni JM, Pupko T (2008) Computational characterization of B-cell epitopes. Mol Immunol 45:3477–3489. doi:10.1016/j.molimm.2007.10.016
60. Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, Michael FS, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA (2013) The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect Immun 81:915–922. doi:10.1128/IAI.01184-12
61. Saha S, Raghava GPS (2006a) AlgPred: prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Res 34:W202–W209. doi:10.1093/nar/gkl343
62. Saha S, Raghava GPS (2006b) Prediction of continuous B-cell epitopes in an antigen using recurrent neural network. Proteins Struct Funct Bioinform 65:40–48. doi:10.1002/prot.21078
63. Sahay A, Shakya M (2010) In silico analysis and homology modelling of antioxidant proteins of Spinach. J Proteomics Bioinform 3:148–154. doi:10.4172/jpb.1000134
64. San Roman B, Garrido V, Grillo MJ (2013) Non-typhoidal Salmonellosis. In: Giese M (ed) Molecular vaccines. Springer, Berlin, pp 329–342
65. Sandkvist M (2001) Type II secretion and pathogenesis. Infect Immun 69:3523–3535. doi:10.1128/IAI.69.6.3523-3535.2001
66. Schmiel DH, Miller VL (1999) Bacterial phospholipases and pathogenesis. Microbes Infect 1:1103–1112. doi:10.1016/S1286-4579(99)00205-1
67. Shankarkumar U (2010) Complexities and similarities of HLA antigen distribution in Asian subcontinent. Indian J Hum Genet 16:108. doi:10.4103/0971-6866.73397
68. Shen HB, Chou KC (2007) Signal-3L: a 3-layer approach for predicting signal peptides. Biochem Biophys Res Commun 363:297–303. doi:10.1016/j.bbrc.2007.08.140
69. Simossis VA, Heringa J (2005) PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Res 33:W289–W294. doi:10.1093/nar/gki390
70. Singh H, Raghava GPS (2001) ProPred: prediction of HLA-DR binding sites. Bioinformatics 17:1236–1237. doi:10.1093/bioinformatics/17.12.1236
71. Singh H, Raghava GPS (2003) ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics 19:1009–1014. doi:10.1093/bioinformatics/btg108
72. Singh H, Ansari HR, Raghava GP (2013) Improved method for linear B-cell epitope prediction using Antigen’s primary sequence. PLoS ONE 8:e62216. doi:10.1371/journal.pone.0062216
73. Somvanshi P, Singh V, Seth PK (2008) In silico prediction of epitopes in virulence proteins of Mycobacterium tuberculosis H37Rv for diagnostic and subunit vaccine design. J Proteomics Bioinform 1:143–153. doi:10.4172/jpb.1000020
74. Stanford K, Brogden KA, McClelland LA, Kozub GC, Audibert F (1998) The incidence of caseous lymphadenitis in Alberta sheep and assessment of impact by vaccination with commercial and experimental vaccines. Can J Vet Res 62:38
75. Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Dore J (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65:4799–4807
76. Sun J, Wu D, Xu T, Wang X, Xu X, Tao L, Li YX, Cao ZW (2009) SEPPA: a computational server for spatial epitope prediction of protein antigens. Nucleic Acids Res 37:W612–W616. doi:10.1093/nar/gkp417
77. Sweredoski MJ, Baldi P (2008) PEPITO: improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure. Bioinformatics 24:1459–1460. doi:10.1093/bioinformatics/btn199
78. Teixeira LM, Merquior VLC (2013) Enterococcus. In: de Filippis I, Mc Kee ML (eds) Molecular typing in bacterial infections. Springer, Berlin, pp 17–26
79. Timasheff SN, Xie G (2003) Preferential interactions of urea with lysozyme and their linkage to protein denaturation. Biophys Chem 105:421–448. doi:10.1016/S0301-4622(03)00106-6
80. Towner KJ (2009) Acinetobacter: an old friend, but a new enemy. J Hosp Infect 73:355–363. doi:10.1016/j.jhin.2009.03.032
81. Xu J, Zhang Y (2010) How significant is a protein structure similarity with TM-score = 0.5? Bioinformatics 26:889–895. doi:10.1093/bioinformatics/btq066
82. Xu D, Zhang Y (2011) Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophys J 101:2525–2534. doi:10.1016/j.bpj.2011.10.024
83. Yang H, Roberts MF (2002) Cloning, overexpression, and characterization of a bacterial Ca2+-dependent phospholipase D. Protein Sci 11:2958–2968. doi:10.1110/ps.0225302
84. Yasser EM, Honavar V (2010) Recent advances in B-cell epitope prediction methods. Immunom Res 6:S2. doi:10.1186/1745-7580-6-S2-S2
85. Young N (2011) Optimizing, purification and inactivation of recombinant Corynebacterium pseudotuberculosis phospholipase D. Dissertation, Occidental College
86. Yu P (2005) Protein secondary structures (a-helix and b-sheet) at a cellular level and protein fractions in relation to rumen degradation behaviours of protein: a new approach. Br J Nutr 94:655–665. doi:10.1079/BJN20051532
87. Yu CS, Chen YC, Lu CH, Hwang JK (2006) Prediction of protein subcellular localization. Proteins Struct Funct Bioinform 64:643–651. doi:10.1002/prot.21018
88. Zhang Y (2009) Protein structure prediction: when is it useful? Curr Opin Struct Biol 19:145–155. doi:10.1016/j.sbi.2009.02.005
89. Zhang R, Ou HY, Zhang CT (2004) DEG: a database of essential genes. Nucleic Acids Res 32:D271–D272. doi:10.1093/nar/gkh024
90. Zhang Q, Wang P, Kim Y, Haste-Andersen P, Beaver J, Bourne PE, Bui HH, Buus S, Frankild S, Greenbaum J (2008) Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res 36:W513–W518. doi:10.1093/nar/gkn254